466 related articles for article (PubMed ID: 27617853)
41. Resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver: does size define the best oncological strategy?
Adam R; Bhangui P; Vibert E; Azoulay D; Pelletier G; Duclos-Vallée JC; Samuel D; Guettier C; Castaing D
Ann Surg; 2012 Dec; 256(6):883-91. PubMed ID: 23108125
[TBL] [Abstract][Full Text] [Related]
42. Impact of clinically evident portal hypertension on the course of hepatocellular carcinoma in patients listed for liver transplantation.
Faitot F; Allard MA; Pittau G; Ciacio O; Adam R; Castaing D; Cunha AS; Pelletier G; Cherqui D; Samuel D; Vibert E
Hepatology; 2015 Jul; 62(1):179-87. PubMed ID: 25914217
[TBL] [Abstract][Full Text] [Related]
43. Section 2. Small-for-size liver graft and hepatocellular carcinoma recurrence.
Chan SC
Transplantation; 2014 Apr; 97 Suppl 8():S7-S10. PubMed ID: 24849840
[TBL] [Abstract][Full Text] [Related]
44. Living donor liver transplantation of the right lobe for hepatocellular carcinoma in cirrhosis in a European center.
Jonas S; Mittler J; Pascher A; Schumacher G; Theruvath T; Benckert C; Rudolph B; Neuhaus P
Liver Transpl; 2007 Jun; 13(6):896-903. PubMed ID: 17538994
[TBL] [Abstract][Full Text] [Related]
45. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
[TBL] [Abstract][Full Text] [Related]
46. Delta-slope of alpha-fetoprotein improves the ability to select liver transplant patients with hepatocellular cancer.
Lai Q; Inostroza M; Rico Juri JM; Goffette P; Lerut J
HPB (Oxford); 2015 Dec; 17(12):1085-95. PubMed ID: 26373980
[TBL] [Abstract][Full Text] [Related]
47. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
[TBL] [Abstract][Full Text] [Related]
48. Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation.
Taketomi A; Sanefuji K; Soejima Y; Yoshizumi T; Uhciyama H; Ikegami T; Harada N; Yamashita Y; Sugimachi K; Kayashima H; Iguchi T; Maehara Y
Transplantation; 2009 Feb; 87(4):531-7. PubMed ID: 19307789
[TBL] [Abstract][Full Text] [Related]
49. When to call it off: defining transplant candidacy limits in liver donor liver transplantation for hepatocellular carcinoma.
Bhatti ABH; Qureshi AI; Tahir R; Dar FS; Khan NY; Zia HH; Riyaz S; Rana A
BMC Cancer; 2020 Aug; 20(1):754. PubMed ID: 32787864
[TBL] [Abstract][Full Text] [Related]
50. Primary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survival.
Moon JI; Kwon CH; Joh JW; Choi GS; Jung GO; Kim JM; Shin M; Choi SJ; Kim SJ; Lee SK
Transplant Proc; 2012 Mar; 44(2):487-93. PubMed ID: 22410053
[TBL] [Abstract][Full Text] [Related]
51. Factors affecting recurrence and survival after living donor liver transplantation for hepatocellular carcinoma.
Abdel-Wahab M; Sultan AM; Fathy OM; Salah T; Elshobary MM; Elghawalby NA; Yassen AM; Elsarraf WM; Elsaadany MF; Zalatah K
Hepatogastroenterology; 2013; 60(128):1847-53. PubMed ID: 24719918
[TBL] [Abstract][Full Text] [Related]
52. Living donor liver transplantation in hepatocellular carcinoma beyond the Milan criteria.
Woo HY; Jang JW; Choi JY; You CR; Jeong SW; Bae SH; Yoon SK; Lee YS; Kim DG
Liver Int; 2008 Sep; 28(8):1120-8. PubMed ID: 18492023
[TBL] [Abstract][Full Text] [Related]
53. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series.
Sugawara Y; Tamura S; Makuuchi M
Dig Dis; 2007; 25(4):310-2. PubMed ID: 17960065
[TBL] [Abstract][Full Text] [Related]
54. Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry.
Schlansky B; Chen Y; Scott DL; Austin D; Naugler WE
Liver Transpl; 2014 Sep; 20(9):1045-56. PubMed ID: 24838471
[TBL] [Abstract][Full Text] [Related]
55. Salvage Versus Primary Liver Transplantation for Early Hepatocellular Carcinoma: Do Both Strategies Yield Similar Outcomes?
Bhangui P; Allard MA; Vibert E; Cherqui D; Pelletier G; Cunha AS; Guettier C; Vallee JC; Saliba F; Bismuth H; Samuel D; Castaing D; Adam R
Ann Surg; 2016 Jul; 264(1):155-63. PubMed ID: 26649581
[TBL] [Abstract][Full Text] [Related]
56. Surgical results for recurrent hepatocellular carcinoma after curative hepatectomy: Repeat hepatectomy versus salvage living donor liver transplantation.
Yamashita Y; Yoshida Y; Kurihara T; Itoh S; Harimoto N; Ikegami T; Yoshizumi T; Uchiyama H; Shirabe K; Maehara Y
Liver Transpl; 2015 Jul; 21(7):961-8. PubMed ID: 25772591
[TBL] [Abstract][Full Text] [Related]
57. Comparison of the outcomes of patients who underwent deceased-donor or living-donor liver transplantation after successful downstaging therapy.
Lei J; Yan L; Wang W
Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1340-6. PubMed ID: 23652915
[TBL] [Abstract][Full Text] [Related]
58. Clinical analysis of recurrent hepatocellular carcinoma after living donor liver transplantation.
Yoon YC; Hong TH; You YK; Kim DG
Clin Transplant; 2013; 27(2):E192-8. PubMed ID: 23383956
[TBL] [Abstract][Full Text] [Related]
59. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation.
Fisher RA; Kulik LM; Freise CE; Lok AS; Shearon TH; Brown RS; Ghobrial RM; Fair JH; Olthoff KM; Kam I; Berg CL;
Am J Transplant; 2007 Jun; 7(6):1601-8. PubMed ID: 17511683
[TBL] [Abstract][Full Text] [Related]
60. Risk factors of hepatocellular carcinoma recurrence after liver transplantation: accuracy of the alpha-fetoprotein model in a single-center experience.
Varona MA; Soriano A; Aguirre-Jaime A; Garrido S; Oton E; Diaz D; Portero J; Bravo P; Barrera MA; Perera A
Transplant Proc; 2015; 47(1):84-9. PubMed ID: 25645778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
